Pub Date : 2019-08-12DOI: 10.33552/wjgwh.2019.02.000544
Sofoudis Chrisostomos, Moschopoulou Sevasti, Apessou Dimitra, Manes Konstantinos, Fagrezos Dimitrios, Karouta Afroditi, S. MayiTsonga, Gerolymatos Andreas
Sofoudis Chrisostomos1*, Moschopoulou Sevasti1, Apessou Dimitra2, Manes Konstantinos3, Fagrezos Dimitrios4, Karouta Afroditi5 and Gerolymatos Andreas1 1Department of Obstetrics and Gynecology, Konstandopoulio General Hospital Athens, Greece 2Department of Pathology, Konstandopoulio General Hospital Athens, Greece 3Department of Surgery, Konstandopoulio General Hospital Athens, Greece 4Department of Computed Tomography, Konstandopoulio General Hospital Athens, Greece 5Department of Ultrasound, Konstandopoulio General Hospital Athens, Greece
Pub Date : 2019-08-12DOI: 10.33552/wjgwh.2019.02.000547
A. Cervera, Denise Umpierrez Morley, Mary-Jane McEneaney, Ladin Yurteri Kaplan
{"title":"Struvite “Sand” in the Vagina as Diagnostic Factor for New-onset Vesicovaginal Fistula and Pessary Management When Present","authors":"A. Cervera, Denise Umpierrez Morley, Mary-Jane McEneaney, Ladin Yurteri Kaplan","doi":"10.33552/wjgwh.2019.02.000547","DOIUrl":"https://doi.org/10.33552/wjgwh.2019.02.000547","url":null,"abstract":"","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43192916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-07-19DOI: 10.33552/wjgwh.2019.02.000543
Sima Ole B
Introduction: cervical cancer is a common cancer. It is accessible for early detection and treatment. The aim was to describe and analyze the lesions observed and their management with a view to reducing the rate of female cancer morbidity and death in Gabon. Methodology: this was a 31-day descriptive and analytical cross-sectional study over two successive years (2017 and 2018), 62 days. All women who consulted for cervical cancer screening were enrolled. Visual inspection methods (VIA/IVIL) were the procedure method, a biopsy was indicated or not, and management was codified. A simple descriptive analysis and the results expressed as a percentage and on average were performed. Results: the target population was 629 women (45.45%) in 2017 and 755 (54.55%) in 2018, or 1,384 women and an increase of 9.10%. The average age of women was 37.02±1.2 years [15-72 years]. The 25-39 age groups were the most represented (51.5%), 24.4% were over 50 and 68.56% were single. There were as many IELG (4.77%) as there were IELHG (4.48%). Eight cases of invasive cancer (0.58%) were found including 3 cases in the 15-24 age. All precancerous lesions were immediately treated and all 8 cancers were surgically treated after Multidisciplinary Consultation Meeting (MCM) Conclusion: organized screening and efficient use of resources reduce the mortality of women from cervical cancer. Key words: cervical cancer-screening-VIA/VIL-mother mortality.
简介:子宫颈癌是一种常见的癌症。它易于早期发现和治疗。目的是描述和分析观察到的病变及其管理，以降低加蓬女性癌症发病率和死亡率。方法:这是一项为期31天的描述性和分析性横断面研究，连续两年(2017年和2018年)，共62天。所有接受子宫颈癌筛查咨询的妇女都被纳入研究。目视检查方法(VIA/IVIL)为程序方法，是否需要活检，并制定了管理方法。一个简单的描述性分析和结果表示为百分比和平均执行。结果:2017年的目标人群为629名女性(45.45%)，2018年为755名女性(54.55%)，增加了1384名女性，增加了9.10%。女性平均年龄为37.02±1.2岁[15-72岁]。25-39岁年龄段占比最高(51.5%)，50岁以上占24.4%，单身占68.56%。IELG人数(4.77%)与IELHG人数(4.48%)相当。浸润性癌8例(0.58%)，其中15 ~ 24岁3例。多学科会诊会议(MCM)后，所有癌前病变均立即得到治疗，8例癌均行手术治疗。结论:有组织的筛查和有效的资源利用降低了宫颈癌妇女的死亡率。关键词:宫颈癌筛查- via / vil -母亲死亡率;
{"title":"Analysis of The Results of Cervical Cancer Screening Campaigns at Owendo’s CHU Maternity Hospital","authors":"Sima Ole B","doi":"10.33552/wjgwh.2019.02.000543","DOIUrl":"https://doi.org/10.33552/wjgwh.2019.02.000543","url":null,"abstract":"Introduction: cervical cancer is a common cancer. It is accessible for early detection and treatment. The aim was to describe and analyze the lesions observed and \u0000their management with a view to reducing the rate of female cancer morbidity and death in Gabon. \u0000Methodology: this was a 31-day descriptive and analytical cross-sectional study over two successive years (2017 and 2018), 62 days. All women who consulted for \u0000cervical cancer screening were enrolled. Visual inspection methods (VIA/IVIL) were the procedure method, a biopsy was indicated or not, and management was \u0000codified. A simple descriptive analysis and the results expressed as a percentage and on average were performed. \u0000Results: the target population was 629 women (45.45%) in 2017 and 755 (54.55%) in 2018, or 1,384 women and an increase of 9.10%. The average age of women \u0000was 37.02±1.2 years [15-72 years]. The 25-39 age groups were the most represented (51.5%), 24.4% were over 50 and 68.56% were single. There were as many \u0000IELG (4.77%) as there were IELHG (4.48%). Eight cases of invasive cancer (0.58%) were found including 3 cases in the 15-24 age. All precancerous lesions were \u0000immediately treated and all 8 cancers were surgically treated after Multidisciplinary Consultation Meeting (MCM) \u0000Conclusion: organized screening and efficient use of resources reduce the mortality of women from cervical cancer. \u0000Key words: cervical cancer-screening-VIA/VIL-mother mortality.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42507261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-07-17DOI: 10.33552/wjgwh.2019.02.000542
B SimaOle, C. O. Mounguengui, R. Obame, G MadiTangani, G MbaEdou, L Ebanga, A MewieLendzinga, B. Ja, S. MayiTsonga, N. Jp, Meye Jf
According to the WHO, induced abortion today is one of the frequent complications of the first trimester of pregnancy and one of the pillars responsible for maternal deaths in low-income countries [1,2]. Worldwide, 20 million at-risk abortions and 80000 deaths per year are recorded or 1/8 deaths. Africa has 3.7 million and 23 miles of deaths as a result of these complications [3]. Abortion is a public health problem that affects women of all ages, but especially young women who are less financially well off and less informed about family planning services. Moreover, these are most often advanced clinical forms and their management is often delayed [1]. This delay is multifactorial. In 2009, a series produced by Mayi-Tsonga and al. At the Libreville University Hospital showed that women died from unsafe abortions. These deaths were related to long delays in receiving emergency obstetric care (EOC) [4]. The authorities then supported the recommendations of the Hospital Committee on Maternal Mortality, which called for shortening delays and also improving the care of women suffering from abortion complications. This explains why the Gabonese Society of Obstetric Gynecology and Reproduction (GSOGR) have agreed to participate in the FIGO initiative for the prevention of unsafe abortions and their consequences [5]. For example, hospitals have introduced manual intra-uterine aspiration training (MIA) into health care provider. It is a method of uterine evacuation that mobilizes few means, accessible by all health formations and preserves fertility by avoiding immediate complications. It can be made using syringe Abstract Objective: Describe and analyze the practice of MIA in our environment with a view of contributing to the reduction of morbidity and maternal mortality.
{"title":"Practice of Manual Intrauterine Aspiration for Post- Abortion Care (PAC): Prospective Study of 137 Cases at Owendo’s CHU Maternity Hospital","authors":"B SimaOle, C. O. Mounguengui, R. Obame, G MadiTangani, G MbaEdou, L Ebanga, A MewieLendzinga, B. Ja, S. MayiTsonga, N. Jp, Meye Jf","doi":"10.33552/wjgwh.2019.02.000542","DOIUrl":"https://doi.org/10.33552/wjgwh.2019.02.000542","url":null,"abstract":"According to the WHO, induced abortion today is one of the frequent complications of the first trimester of pregnancy and one of the pillars responsible for maternal deaths in low-income countries [1,2]. Worldwide, 20 million at-risk abortions and 80000 deaths per year are recorded or 1/8 deaths. Africa has 3.7 million and 23 miles of deaths as a result of these complications [3]. Abortion is a public health problem that affects women of all ages, but especially young women who are less financially well off and less informed about family planning services. Moreover, these are most often advanced clinical forms and their management is often delayed [1]. This delay is multifactorial. In 2009, a series produced by Mayi-Tsonga and al. At the Libreville University Hospital showed that women died from unsafe abortions. These deaths were related to long delays in receiving emergency obstetric care (EOC) [4]. The authorities then supported the recommendations of the Hospital Committee on Maternal Mortality, which called for shortening delays and also improving the care of women suffering from abortion complications. This explains why the Gabonese Society of Obstetric Gynecology and Reproduction (GSOGR) have agreed to participate in the FIGO initiative for the prevention of unsafe abortions and their consequences [5]. For example, hospitals have introduced manual intra-uterine aspiration training (MIA) into health care provider. It is a method of uterine evacuation that mobilizes few means, accessible by all health formations and preserves fertility by avoiding immediate complications. It can be made using syringe Abstract Objective: Describe and analyze the practice of MIA in our environment with a view of contributing to the reduction of morbidity and maternal mortality.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49241341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-10DOI: 10.33552/WJGWH.2019.02.000541
G. Vilos
A 38-year-old woman underwent a routine/uneventful abdominal hysterectomy for abnormal uterine bleeding (AUB) and uterine fibroids. Approximately 24 hours later, she developed severe hyponatremia (Na = 118 mEq/L), brain edema and coma, and she died 3 days later. The mechanism of hyponatremia was, likely, due to excessive and/or inappropriate fluid infusion of 2/3:1/3 solution. The inability to regulate her fluids and electrolytes (Na and K), was, likely, related to addback estrogen therapy given for 3 months preoperatively in conjunction with a GnRH agonist to optimize the patient’s hemoglobin and shrink the uterus/fibroids. It has been known that postmenopausal women and men can regulate excessive hyponatremic fluid absorption and electrolytes better than premenopausal women implicating an estrogen role. Estrogen has been found to inhibit the Na/K-ATPase pump in a variety of tissues/organs including the brain. This woman’s pathology of the endometrium was reported as proliferative indicating that enough estrogen may have been available to inhibit her Na/K-ATPase pump resulting in inability to regulate her fluids and electrolytes leading to her death.
一位38岁的女性因异常子宫出血(AUB)和子宫肌瘤接受了常规/平稳的腹部子宫切除术。约24小时后，患者出现严重低钠血症(Na = 118 mEq/L)、脑水肿和昏迷，3天后死亡。低钠血症的机制可能是由于过量和/或不适当的液体输注2/3:1/3溶液。无法调节她的液体和电解质(钠和钾)，可能与术前3个月的补品雌激素治疗联合GnRH激动剂以优化患者的血红蛋白和缩小子宫/肌瘤有关。众所周知，绝经后的女性和男性可以比绝经前的女性更好地调节过度的低钠血症液体吸收和电解质，这意味着雌激素的作用。雌激素已被发现可以抑制包括大脑在内的多种组织/器官中的Na/ k - atp酶泵。据报道，这名妇女的子宫内膜病理呈增生性，表明可能有足够的雌激素可用于抑制她的Na/ k - atp酶泵，导致无法调节她的液体和电解质，导致她死亡。
{"title":"Death from Acute Hyponatremia Following Uneventful Abdominal Hysterectomy: Lessons from a Case Report","authors":"G. Vilos","doi":"10.33552/WJGWH.2019.02.000541","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000541","url":null,"abstract":"A 38-year-old woman underwent a routine/uneventful abdominal hysterectomy for abnormal uterine bleeding (AUB) and uterine fibroids. Approximately 24 hours later, she developed severe hyponatremia (Na = 118 mEq/L), brain edema and coma, and she died 3 days later. The mechanism of hyponatremia was, likely, due to excessive and/or inappropriate fluid infusion of 2/3:1/3 solution. The inability to regulate her fluids and electrolytes (Na and K), was, likely, related to addback estrogen therapy given for 3 months preoperatively in conjunction with a GnRH agonist to optimize the patient’s hemoglobin and shrink the uterus/fibroids. It has been known that postmenopausal women and men can regulate excessive hyponatremic fluid absorption and electrolytes better than premenopausal women implicating an estrogen role. Estrogen has been found to inhibit the Na/K-ATPase pump in a variety of tissues/organs including the brain. This woman’s pathology of the endometrium was reported as proliferative indicating that enough estrogen may have been available to inhibit her Na/K-ATPase pump resulting in inability to regulate her fluids and electrolytes leading to her death.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47336780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-03DOI: 10.33552/WJGWH.2019.02.000540
B. Petrikovsky
In 2008, the American College of Obstetricians and Gynecologists (ACOG) put together a special committee to produce recommendations on the role of transvaginal sonography to evaluate endometrium in postmenopausal women [1]. Transvaginal ultrasonography usually is sufficient for an initial evaluation of postmenopausal bleeding if the ultrasound images reveal a thin endometrial echo (less than or equal to 4 mm), given that an endometrial thickness of 4mm or less has a greater than 99% negative predictive value for endometrial value for endometrial cancer [1].
{"title":"Importance of Sonographic Endometrial Morphology in Detecting Hyperplasia and Carcinoma","authors":"B. Petrikovsky","doi":"10.33552/WJGWH.2019.02.000540","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000540","url":null,"abstract":"In 2008, the American College of Obstetricians and Gynecologists (ACOG) put together a special committee to produce recommendations on the role of transvaginal sonography to evaluate endometrium in postmenopausal women [1]. Transvaginal ultrasonography usually is sufficient for an initial evaluation of postmenopausal bleeding if the ultrasound images reveal a thin endometrial echo (less than or equal to 4 mm), given that an endometrial thickness of 4mm or less has a greater than 99% negative predictive value for endometrial value for endometrial cancer [1].","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45744605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-05-28DOI: 10.33552/WJGWH.2019.02.000539
A. Gabra, M. Gabra
Hypertensive disorders of pregnancy (HDP) were discovered a long time ago but our knowledge about their etiopathogenesis are still limited. These disorders can affect many pregnant women all over the world putting them, their families and their countries under significant health burden. The main goal of all research efforts regarding treatment of HDP is how to prevent highly morbid complications and mortality of HDP that may affect both mother and fetus. Delivery is the main line of treatment for severe cases but we have to put in our mind risk of prematurity as a possible outcome in case of termination besides the possibility of incidence of complications like eclampsia and hypertensive emergency postnatally. Researchers believed that studies working on prevention would result in major improvement of overall women care worldwide, and screening will definitely allow prompt starting therapy for those patients and prevent further sequences. Recently many guidelines support and recommend Aspirin 81 mg for the prevention of preeclampsia in high-risk patients using evidence-based data about the time and indications of its intake. Great efforts have been contributed to developing evidence-based guidelines to enhance our strategies to deal with these disorders. Reviewing, pooling and comparing these guidelines would help us to refine our questions that may need to be answered by further studies. Trials confirmed that application of standardized strategies for treating HDP significantly improves both maternal and fetal outcomes. In this article, we are going to review recent updates and guidelines about the treatment of HDP and provide references for your further readings.
{"title":"Updates in Management of Hypertensive Disorders of Pregnancy","authors":"A. Gabra, M. Gabra","doi":"10.33552/WJGWH.2019.02.000539","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000539","url":null,"abstract":"Hypertensive disorders of pregnancy (HDP) were discovered a long time ago but our knowledge about their etiopathogenesis are still limited. These disorders can affect many pregnant women all over the world putting them, their families and their countries under significant health burden. The main goal of all research efforts regarding treatment of HDP is how to prevent highly morbid complications and mortality of HDP that may affect both mother and fetus. Delivery is the main line of treatment for severe cases but we have to put in our mind risk of prematurity as a possible outcome in case of termination besides the possibility of incidence of complications like eclampsia and hypertensive emergency postnatally. Researchers believed that studies working on prevention would result in major improvement of overall women care worldwide, and screening will definitely allow prompt starting therapy for those patients and prevent further sequences. Recently many guidelines support and recommend Aspirin 81 mg for the prevention of preeclampsia in high-risk patients using evidence-based data about the time and indications of its intake. Great efforts have been contributed to developing evidence-based guidelines to enhance our strategies to deal with these disorders. Reviewing, pooling and comparing these guidelines would help us to refine our questions that may need to be answered by further studies. Trials confirmed that application of standardized strategies for treating HDP significantly improves both maternal and fetal outcomes. In this article, we are going to review recent updates and guidelines about the treatment of HDP and provide references for your further readings.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44959038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-05-22DOI: 10.33552/WJGWH.2019.02.000538
H. A. Shamahy
Background: Bad obstetric history (BOH) comprises of previous adverse fetal consequences in terms of two or more successive spontaneous abortions, early neonatal deaths, stillbirths, intrauterine fetal deaths, intrauterine growth retardations and congenital anomalies. The infections which are caused by Rubella virus and CMV during pregnancy are often associated with adverse fetus outcomes and reproductive failures. In the Yemen context, the exact seroprevalence of these infections is not known due to unavailability of baseline data. Objectives: The main aim of this study was to determine the correlation of the main viral TORCH infections (Rubella and CMV) during pregnancy among Yemeni females with BOH. Methods: Two hundred- sixty-eight serum samples were collected from participants having BOH, attending Department of Obstetrics and Gynecology, Al-Sabian University hospital, Sana’a city during the period of September 2017 to September 2018. IgM antibodies for Rubella virus and CMV were detected by micro-capture ELISA tests. Results: The common causes of BOH were abortion (52.6%), intrauterine fetal death (22%) followed by intrauterine growth retardation (10.4%). Fourteen (5.2%) of pregnant women were positive for CMV IgM antibodies, 10 (3.7%) for Rubella IgM antibodies and 4 (1.5%) for CMV- Rubella virus in combination; indicating recent infections. There was significant association between the positive results of anti-CMV IgM -anti-Rubella IgM with age group ≥ 36 years (OR=31,6.2 respectively). Also, there was a significant association between the positive results of anti-CMV IgM with congenital deformation (OR=10.2, p<0.001). Conclusion: IgM antibody positivity was high for Rubella and CMV and there is a strong association of these agents with BOH. Thus, screening and early diagnosis for these pathogens in women can help in proper management of these cases to prevent fetus loss.
{"title":"Association of Cytomegalo-Virus and Rubella Virus Infections in Pregnant Women with bad Obstetric History","authors":"H. A. Shamahy","doi":"10.33552/WJGWH.2019.02.000538","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000538","url":null,"abstract":"Background: Bad obstetric history (BOH) comprises of previous adverse fetal consequences in terms of two or more successive spontaneous abortions, early neonatal deaths, stillbirths, intrauterine fetal deaths, intrauterine growth retardations and congenital anomalies. The infections which are caused by Rubella virus and CMV during pregnancy are often associated with adverse fetus outcomes and reproductive failures. In the Yemen context, the exact seroprevalence of these infections is not known due to unavailability of baseline data. Objectives: The main aim of this study was to determine the correlation of the main viral TORCH infections (Rubella and CMV) during pregnancy among Yemeni females with BOH. Methods: Two hundred- sixty-eight serum samples were collected from participants having BOH, attending Department of Obstetrics and Gynecology, Al-Sabian University hospital, Sana’a city during the period of September 2017 to September 2018. IgM antibodies for Rubella virus and CMV were detected by micro-capture ELISA tests. Results: The common causes of BOH were abortion (52.6%), intrauterine fetal death (22%) followed by intrauterine growth retardation (10.4%). Fourteen (5.2%) of pregnant women were positive for CMV IgM antibodies, 10 (3.7%) for Rubella IgM antibodies and 4 (1.5%) for CMV- Rubella virus in combination; indicating recent infections. There was significant association between the positive results of anti-CMV IgM -anti-Rubella IgM with age group ≥ 36 years (OR=31,6.2 respectively). Also, there was a significant association between the positive results of anti-CMV IgM with congenital deformation (OR=10.2, p<0.001). Conclusion: IgM antibody positivity was high for Rubella and CMV and there is a strong association of these agents with BOH. Thus, screening and early diagnosis for these pathogens in women can help in proper management of these cases to prevent fetus loss.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45896780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-05-03DOI: 10.33552/WJGWH.2019.02.000537
A. Dawood, H. Salem
{"title":"Steroids Administration at Term in Egypt: Does it become a Routine Practice?","authors":"A. Dawood, H. Salem","doi":"10.33552/WJGWH.2019.02.000537","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000537","url":null,"abstract":"","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46057100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：